Blue Jet Healthcare Limited (BLUEJET.BO)
INR 584.1
(1.64%)
INR 584.1
(1.64%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.79 Million INR | -75.53% |
| 2022 | 15.49 Million INR | -88.35% |
| 2021 | 132.95 Million INR | -53.65% |
| 2020 | 286.82 Million INR | -22.33% |
| 2019 | 369.27 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - INR | 0.0% |
| 2024 Q1 | - INR | 0.0% |
| 2023 Q2 | 9.42 Million INR | -24.88% |
| 2023 Q4 | 3.79 Million INR | 0.0% |
| 2023 FY | 3.79 Million INR | -75.53% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | 12.54 Million INR | -19.04% |
| 2022 Q4 | 15.49 Million INR | 0.0% |
| 2022 FY | 15.49 Million INR | -88.35% |
| 2022 Q2 | - INR | 0.0% |
| 2022 Q1 | - INR | 0.0% |
| 2021 FY | 132.95 Million INR | -53.65% |
| 2020 FY | 286.82 Million INR | -22.33% |
| 2019 FY | 369.27 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 99.721% |
| Biocon Limited | 129.32 Billion INR | 99.997% |
| Concord Biotech Limited | 18.87 Million INR | 79.915% |
| Dishman Carbogen Amcis Limited | 2.45 Billion INR | 99.846% |
| FERMENTA BIOTECH LIMITED | 425.36 Million INR | 99.109% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Lyka Labs Limited | 429.06 Million INR | 99.117% |
| Panacea Biotec Limited | 209.9 Million INR | 98.194% |
| SAMSRITA LABS LIMITED | - INR | -Infinity% |
| Servoteach Industries Limited | 5059.00 INR | -74815.991% |
| SMS Lifesciences India Limited | 331.45 Million INR | 98.857% |
| Supriya Lifescience Limited | 50.2 Million INR | 92.45% |
| Syngene International Limited | 1 Billion INR | 99.621% |
| TAKE Solutions Limited | 7.5 Million INR | 49.467% |
| Titan Biotech Limited | 4.53 Million INR | 16.391% |
| Transgene Biotek Limited | 50.79 Million INR | 92.539% |
| Vanta Bioscience Limited | 488.01 Million INR | 99.223% |